This might suggest that the lack of NTproBNP prognostic ability might be attributed to the limited cohort or the narrow NT-proBNP range investigated in the current study, as it was specifically designed to clarify the clinical significance of moderately elevated NT-proBNP, particularly in subjects without HF or relevant valvular heart disease. The gene discussed is NPPB; the disease is heart valve disorder.